RVL Pharmaceuticals plc Announces Result of Proposal to Approve a Waiver of Offer Obligations under Rule 9 of the Irish Takeover Rules at Annual General Meeting
BRIDGEWATER, N.J., June 15, 2023 -- RVL Pharmaceuticals plc , a specialty pharmaceutical company, today announced results of the proposal to approve a waiver of offer obligations under Rule 9 of... | June 15, 2023